Silvia B.
- Country
- Italy
- Department
- Divisione di Ematologia
Research Overview
- An open-label, randomized phase III trial comparing local radiotherapy alone or combined with Obinutuzumab in early stage Follicular Lymphoma: the GAZEBO Trial from the Fondazione Italiana Linfomi
- Randomized European Trial of Autologous Transplantation with Rituximab, Ibrutinib, and Ara-C Induction in Generalized Mantle Cell Lymphoma
- Phase II Evaluation of Mosunetuzumab and Zanubrutinib in Relapsed/Refractory Follicular Lymphoma
Data & Insights
Has run more than one trial at 37 of 193 partner sites.
Specializations
Lymphoma Research
The investigator specializes in treating and studying various forms of lymphoma, with particular focus on Diffuse Large B-Cell Lymphoma and Early Stage Follicular Lymphoma.
- B-Cell Lymphoma Management
- Early-Stage Lymphoma Treatment
- Radiotherapy Applications
Their research encompasses innovative therapeutic approaches in lymphatic cancers.
Treatment Modalities
The investigator explores various treatment combinations involving radiotherapy and targeted immunotherapy approaches for lymphoma patients.
- Combined Therapy Protocols
- Local Radiotherapy Applications
- Immunotherapy Integration
Their work focuses on optimizing treatment strategies for improved patient outcomes.
Clinical Evaluation
The investigator conducts research examining therapeutic efficacy in hematologic malignancies, with emphasis on progression-free survival outcomes.
- Treatment Response Assessment
- Survival Outcome Analysis
- Comparative Treatment Studies
Their research aims to establish evidence-based treatment protocols.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.